You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm's new application of its BCR-ABL test will be able to detect p190 transcripts and is currently for research use only.
Research teams saw a significant number of SARS-CoV-2 infections during an aircraft carrier outbreak and in Marine recruits undergoing strict quarantine.
The assay can be used to pool up to five specimens collected from individuals suspected of having COVID-19 or from asymptomatic patients.
The PCR assay, which runs on the firm's Idylla platform, detects SARS-CoV-2 RNA in nasopharyngeal swabs from patients suspected to have COVID-19.
The company's system revenues were up 28 percent to $19.5 million and consumables revenues dropped 12 percent to $11.8 million.
Fluidigm tallied $39.9 million in revenues compared to $26.5 million a year ago, and well above analysts' consensus estimate of $32.5 million.
The deal with GeneproDx will focus on thyroid cancer, while the agreement with Endpoint Health will focus on CDx development for critical illnesses.
The point-of-care test runs on the VitaPCR instrument and delivers results in 20 minutes, and has been implemented at Charles De Gaulle airport.
The reissued EUA is for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal swab, nasopharyngeal swab, and anterior nasal swab specimens.
COVID-19-related business contributed $288 million in revenues during the quarter, offsetting a 6 percent year-over-year decline in non-COVID-19-related revenues.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.